PriceSeer_data/news_data/CTVA_news.csv

title,source,date,link,content
"Corteva, Inc. (CTVA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates",Yahoo Finance,"Aug 6, 2025",https://finance.yahoo.com/news/corteva-inc-ctva-q2-earnings-223002174.html,"Corteva, Inc. (CTVA) reported $6.46 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 5.6%. EPS of $2.20 for the same period compares to $1.83 a year ago.

The reported revenue represents a surprise of +3.36% over the Zacks Consensus Estimate of $6.25 billion. With the consensus EPS estimate being $1.89, the EPS surprise was +16.4%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Corteva, Inc. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
Is Corteva (CTVA) Stock Outpacing Its Consumer Staples Peers This Year?,Yahoo Finance,"Aug 5, 2025",https://finance.yahoo.com/news/corteva-ctva-stock-outpacing-consumer-134002774.html,"For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Corteva, Inc. (CTVA) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.

Corteva, Inc. is one of 178 individual stocks in the Consumer Staples sector. Collectively, these companies sit at #14 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.

The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Corteva, Inc. is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for CTVA's full-year earnings has moved 0.9% higher within the past quarter. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Our latest available data shows that CTVA has returned about 26.3% since the start of the calendar year. Meanwhile, stocks in the Consumer Staples group have gained about 2.7% on average. This means that Corteva, Inc. is performing better than its sector in terms of year-to-date returns.

One other Consumer Staples stock that has outperformed the sector so far this year is New York Times Co. (NYT). The stock is up 3.3% year-to-date.

In New York Times Co.'s case, the consensus EPS estimate for the current year increased 3.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, Corteva, Inc. belongs to the Agriculture - Operations industry, a group that includes 15 individual stocks and currently sits at #191 in the Zacks Industry Rank. This group has gained an average of 9.9% so far this year, so CTVA is performing better in this area.

In contrast, New York Times Co. falls under the Publishing - Newspapers industry. Currently, this industry has 2 stocks and is ranked #17. Since the beginning of the year, the industry has moved +0.2%.

Going forward, investors interested in Consumer Staples stocks should continue to pay close attention to Corteva, Inc. and New York Times Co. as they could maintain their solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Corteva, Inc. (CTVA) : Free Stock Analysis Report"
FMC vs. CTVA: Which Stock Is the Better Value Option?,Yahoo Finance,"Aug 1, 2025",https://finance.yahoo.com/news/fmc-vs-ctva-stock-better-154002548.html,"Investors interested in Agriculture - Operations stocks are likely familiar with FMC (FMC) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.

There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.

Right now, FMC is sporting a Zacks Rank of #2 (Buy), while Corteva, Inc. has a Zacks Rank of #3 (Hold). This means that FMC's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one piece of the puzzle for value investors.

Value investors analyze a variety of traditional, tried-and-true metrics to help find companies that they believe are undervalued at their current share price levels.

Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.

FMC currently has a forward P/E ratio of 11.66, while CTVA has a forward P/E of 24.03. We also note that FMC has a PEG ratio of 1.26. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. CTVA currently has a PEG ratio of 1.74.

Another notable valuation metric for FMC is its P/B ratio of 1.1. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, CTVA has a P/B of 2.01.

These are just a few of the metrics contributing to FMC's Value grade of B and CTVA's Value grade of D.

FMC has seen stronger estimate revision activity and sports more attractive valuation metrics than CTVA, so it seems like value investors will conclude that FMC is the superior option right now.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

FMC Corporation (FMC) : Free Stock Analysis Report

Corteva, Inc. (CTVA) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research"
"Corteva, Inc. (CTVA) Upgraded to Strong Buy: What Does It Mean for the Stock?",Yahoo Finance,"Jul 16, 2025",https://finance.yahoo.com/news/corteva-inc-ctva-upgraded-strong-160003181.html,"Investors might want to bet on Corteva, Inc. (CTVA), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.

Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.

Therefore, the Zacks rating upgrade for Corteva, Inc. basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.

Most Powerful Force Impacting Stock Prices

The change in a company's future earnings potential, as reflected in earnings estimate revisions, and the near-term price movement of its stock are proven to be strongly correlated. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.

For Corteva, Inc., rising earnings estimates and the consequent rating upgrade fundamentally mean an improvement in the company's underlying business. And investors' appreciation of this improving business trend should push the stock higher.

Harnessing the Power of Earnings Estimate Revisions

As empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.

The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> ."
FMC or CTVA: Which Is the Better Value Stock Right Now?,Yahoo Finance,"Jul 7, 2025",https://finance.yahoo.com/news/fmc-ctva-better-value-stock-154002058.html,"Investors interested in stocks from the Agriculture - Operations sector have probably already heard of FMC (FMC) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.

We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank emphasizes companies with positive estimate revision trends, and our Style Scores highlight stocks with specific traits.

FMC and Corteva, Inc. are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that FMC has an improving earnings outlook. However, value investors will care about much more than just this.

Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.

Our Value category grades stocks based on a number of key metrics, including the tried-and-true P/E ratio, the P/S ratio, earnings yield, and cash flow per share, as well as a variety of other fundamentals that value investors frequently use.

FMC currently has a forward P/E ratio of 13.14, while CTVA has a forward P/E of 25.71. We also note that FMC has a PEG ratio of 1.33. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. CTVA currently has a PEG ratio of 1.97.

Another notable valuation metric for FMC is its P/B ratio of 1.25. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, CTVA has a P/B of 2.15.

These are just a few of the metrics contributing to FMC's Value grade of B and CTVA's Value grade of D.

FMC is currently sporting an improving earnings outlook, which makes it stick out in our Zacks Rank model. And, based on the above valuation metrics, we feel that FMC is likely the superior value option right now.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

FMC Corporation (FMC) : Free Stock Analysis Report

Corteva, Inc. (CTVA) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research"
Corteva (NYSE:CTVA) stock performs better than its underlying earnings growth over last five years,Simply Wall Street,"Jun 18, 2025",https://simplywall.st/stocks/us/materials/nyse-ctva/corteva/news/corteva-nysectva-stock-performs-better-than-its-underlying-e,"When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really flourishing, you can make more than 100%. For instance, the price of Corteva, Inc. ( ) stock is up an impressive 171% over the last five years. Also pleasing for shareholders was the 19% gain in the last three months.

Since the stock has added US$1.8b to its market cap in the past week alone, let's see if underlying performance has been driving long-term returns.

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Over half a decade, Corteva managed to grow its earnings per share at 48% a year. This EPS growth is higher than the 22% average annual increase in the share price. So it seems the market isn't so enthusiastic about the stock these days.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

We know that Corteva has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Corteva will

Advertisement

What About Dividends?

It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for Corteva the TSR over the last 5 years was 187%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

It's nice to see that Corteva shareholders have received a total shareholder return of 45% over the last year. Of course, that includes the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 23% per year), it would seem that the stock's performance has improved in recent times. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. It's always interesting to track share price performance over the longer term. But to understand Corteva better, we need to consider many other factors. Consider for instance, the ever-present spectre of investment risk. , and understanding them should be part of your investment process.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

New: AI Stock Screener & Alerts Our new AI Stock Screener scans the market every day to uncover opportunities. • Dividend Powerhouses (3%+ Yield)

• Undervalued Small Caps with Insider Buying

• High growth Tech and AI Companies



Or build your own from over 50 metrics. Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.



This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned."
$CTVA stock is down 10% today. Here's what we see in our data.,Quiver Quantitative,1 month ago,https://www.quiverquant.com/news/%24CTVA+stock+is+down+10%25+today.+Here%27s+what+we+see+in+our+data.,"$CTVA stock has now fallen 10% today, according to our price data from Polygon. There has been approximately $473,419,246 of trading volume.

$CTVA Insider Trading Activity

Here is what we see in our data on $CTVA (you can track the company live on Quiver's $CTVA stock page ):

$CTVA insiders have traded $CTVA stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CTVA stock by insiders over the last 6 months:

CORNEL B FUERER (See Remarks) sold 55,242 shares for an estimated $3,759,770

ROBERT D. KING (EVP, Crop Protection Business) sold 37,280 shares for an estimated $2,765,993

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CTVA Hedge Fund Activity

We have seen 644 institutional investors add shares of $CTVA stock to their portfolio, and 535 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Receive $CTVA Data Alerts Sign Up

$CTVA Analyst Ratings

Wall Street analysts have issued reports on $CTVA in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Wells Fargo issued a ""Overweight"" rating on 08/08/2025

Keybanc issued a ""Overweight"" rating on 08/08/2025

UBS issued a ""Buy"" rating on 08/07/2025

BMO Capital issued a ""Outperform"" rating on 07/08/2025

Jefferies issued a ""Buy"" rating on 06/06/2025

Oppenheimer issued a ""Outperform"" rating on 05/09/2025

Morgan Stanley issued a ""Overweight"" rating on 05/09/2025

To track analyst ratings and price targets for $CTVA, check out Quiver Quantitative's $CTVA forecast page.

$CTVA Price Targets

Multiple analysts have issued price targets for $CTVA recently. We have seen 11 analysts offer price targets for $CTVA in the last 6 months, with a median target of $85.0.

Here are some recent targets:

Benjamin Theurer from Barclays set a target price of $84.0 on 08/13/2025

on 08/13/2025 Aleksey Yefremov from Keybanc set a target price of $85.0 on 08/08/2025

on 08/08/2025 Richard Garchitorena from Wells Fargo set a target price of $83.0 on 08/08/2025

on 08/08/2025 Joshua Spector from UBS set a target price of $91.0 on 08/07/2025

on 08/07/2025 Kristen Owen from Oppenheimer set a target price of $87.0 on 07/15/2025

on 07/15/2025 Arun Viswanathan from RBC Capital set a target price of $85.0 on 07/10/2025

on 07/10/2025 Joel Jackson from BMO Capital set a target price of $86.0 on 07/08/2025

You can track data on $CTVA on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies."
The Goldman Sachs Group Issues Pessimistic Forecast for Corteva (NYSE:CTVA) Stock Price,MarketBeat,2 weeks ago,https://www.marketbeat.com/instant-alerts/the-goldman-sachs-group-issues-pessimistic-forecast-for-corteva-nysectva-stock-price-2025-10-22/,"Corteva (NYSE:CTVA - Get Free Report) had its price objective decreased by research analysts at The Goldman Sachs Group from $85.00 to $77.00 in a research report issued on Wednesday,MarketScreener reports. The firm presently has a ""buy"" rating on the stock. The Goldman Sachs Group's price target would suggest a potential upside of 24.04% from the company's current price.

Several other equities research analysts have also weighed in on the stock. JPMorgan Chase & Co. raised shares of Corteva from a ""neutral"" rating to an ""overweight"" rating and set a $67.00 target price on the stock in a report on Thursday, October 2nd. Royal Bank Of Canada lowered their target price on shares of Corteva from $86.00 to $80.00 and set an ""outperform"" rating on the stock in a report on Friday, October 17th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Corteva from $83.00 to $90.00 and gave the stock a ""buy"" rating in a report on Monday, September 15th. Mizuho reduced their price target on shares of Corteva from $85.00 to $78.00 and set an ""outperform"" rating on the stock in a research report on Wednesday, October 8th. Finally, Jefferies Financial Group reduced their price target on shares of Corteva from $92.00 to $85.00 in a research report on Thursday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of ""Moderate Buy"" and an average target price of $79.94.

Get Corteva alerts: Sign Up

Read Our Latest Stock Analysis on CTVA

Corteva Stock Performance

Corteva stock traded up $0.11 on Wednesday, hitting $62.08. The company's stock had a trading volume of 101,024 shares, compared to its average volume of 4,006,164. The firm has a market cap of $42.16 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.42 and a beta of 0.76. The company has a quick ratio of 1.23, a current ratio of 1.68 and a debt-to-equity ratio of 0.06. The company has a fifty day moving average price of $69.04 and a 200-day moving average price of $68.97. Corteva has a one year low of $53.40 and a one year high of $77.41.

Corteva (NYSE:CTVA - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.89 by $0.31. The firm had revenue of $6.46 billion for the quarter, compared to analyst estimates of $6.26 billion. Corteva had a net margin of 8.16% and a return on equity of 8.68%. The business's revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.83 EPS. On average, equities analysts anticipate that Corteva will post 2.96 earnings per share for the current year.

Insider Transactions at Corteva

In other news, EVP Robert D. King sold 37,280 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the completion of the transaction, the executive vice president directly owned 49,262 shares of the company's stock, valued at $3,655,240.40. This trade represents a 43.08% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.15% of the company's stock.

Hedge Funds Weigh In On Corteva

Hedge funds have recently made changes to their positions in the business. Gladwyn Financial Advisors Inc. bought a new position in shares of Corteva in the second quarter valued at $25,000. Total Investment Management Inc. bought a new position in shares of Corteva in the second quarter valued at $27,000. Curat Global LLC grew its stake in shares of Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company's stock valued at $28,000 after buying an additional 179 shares in the last quarter. Maryland Capital Advisors Inc. bought a new position in shares of Corteva in the second quarter valued at $29,000. Finally, True Wealth Design LLC grew its stake in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company's stock valued at $26,000 after buying an additional 264 shares in the last quarter. 81.54% of the stock is owned by institutional investors.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Corteva, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.

While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here"
"Here's Why Corteva, Inc. (CTVA) is Poised for a Turnaround After Losing 15% in 4 Weeks",Nasdaq,1 month ago,https://www.nasdaq.com/articles/heres-why-corteva-inc-ctva-poised-turnaround-after-losing-15-4-weeks,"Corteva, Inc. (CTVA) has been on a downward spiral lately with significant selling pressure. After declining 15.1% over the past four weeks, the stock looks well positioned for a trend reversal as it is now in oversold territory and there is strong agreement among Wall Street analysts that the company will report better earnings than they predicted earlier.

We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.

RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.

Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.

So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.

However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.

Why a Trend Reversal is Due for CTVA

The heavy selling of CTVA shares appears to be in the process of exhausting itself, as indicated by its RSI reading of 21.08. So, the trend for the stock could reverse soon for reaching the old equilibrium of supply and demand.

The RSI value is not the only factor that indicates a potential turnaround for the stock in the near term. On the fundamental side, there has been strong agreement among the sell-side analysts covering the stock in raising earnings estimates for the current year. Over the last 30 days, the consensus EPS estimate for CTVA has increased 1.3%. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.

Moreover, CTVA currently has a Zacks Rank #1 (Strong Buy), which means it is in the top 5% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Free Report: Profiting from the 2nd Wave of AI Explosion

The next phase of the AI explosion is poised to create significant wealth for investors, especially those who get in early. It will add literally trillion of dollars to the economy and revolutionize nearly every part of our lives.

Investors who bought shares like Nvidia at the right time have had a shot at huge gains.

But the rocket ride in the ""first wave"" of AI stocks may soon come to an end. The sharp upward trajectory of these stocks will begin to level off, leaving exponential growth to a new wave of cutting-edge companies.

Zacks' AI Boom 2.0: The Second Wave report reveals 4 under-the-radar companies that may soon be shining stars of AI’s next leap forward.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Corteva, Inc. (CTVA) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc."
Corteva Sinks 9% As It Plans to Split Into Two Seperate Companies,TIKR.com,1 month ago,https://www.tikr.com/blog/corteva-sinks-9-as-it-plans-to-split-into-two-seperate-companies,"Key Stats for Corteva Stock

Price Change for $CTVA stock: -9%

-9% Current Share Price: $15.37

$15.37 52-Week High: $20

$20 $CTVA Stock Price Target: $13.73

Unlock our Free Report: 5 undervalued compounders with upside based on Wall Street’s growth estimates that could deliver market-beating returns (Sign up for TIKR, it’s free) >>>

What Happened?

Corteva Agriscience (CTVA) stock dropped 9% after the agricultural technology company announced plans to split into two separate publicly traded companies by the second half of 2026.

The move will separate CTVA’s current Crop Protection business (which will become “New Corteva”) from its Seed business (which will be called “SpinCo”).

CEO Chuck Magro emphasized that the decision comes from a position of strength, not weakness. Over the past six years, Corteva has delivered an 11% compound annual growth rate in operating EBITDA and expanded margins by more than 700 basis points.

The company has returned $7 billion to shareholders during that period while delivering a roughly 200% total shareholder return.

CTVA Stock Price Performance (TIKR)

Management argues that the seed and crop protection markets have evolved in ways that require different strategies going forward.

The split will allow each business to pursue its own growth path without being constrained by the other. Current Chairman Greg Page will lead New Corteva, while CEO Chuck Magro will take the helm at SpinCo.

See analysts’ growth forecasts and price targets for Corteva stock (It’s free!) >>>

What the Market Is Telling Us About CTVA Stock

The 7% sell-off in CTVA stock suggests investors are skeptical about the rationale for the split. While management framed this as a proactive move to stay ahead of the market, Wall Street appears concerned about potential risks and execution challenges.

The company estimates separation costs of $80 million to $100 million in dis-synergies, which management considers manageable.

Both businesses will maintain investment-grade credit ratings and have distinct capital allocation strategies.

New Corteva will retain legacy liabilities, including PFAS obligations and the historical DuPont pension plan, which have raised questions from analysts about why these weren’t split between the two entities.

Management pushed back on investor concerns about hidden liabilities, stating explicitly that there are “no surprises” regarding crop protection product liability contingencies.

They argue that CTVA’s integrated model worked well for the past six years, but the future requires different approaches.

The crop protection business needs to focus on cost efficiency and operational excellence, while the seed business can expand into new markets, such as hybrid wheat, gene editing, and biofuels.

CTVA Stock Valuation Model (TIKR)

Some investors may be worried that breaking up the integrated seed-and-chemical model eliminates synergies, particularly around products like Enlist.

However, Corteva counters that future systems will be “open source” with multiple modes of action from different companies, making integration less critical.

The market will be watching closely as CTVA navigates the separation process over the next 18 months to determine if management’s long-term vision justifies the near-term uncertainty.

Value CTVA stock with TIKR’s Valuation Model today for FREE (It’s the easiest way to find undervalued stocks) >>>

Wall Street Analysts Are Bullish on These 5 Undervalued Compounders With Market-Beating Potential

TIKR just released a new free report on 5 compounders that appear undervalued, have beaten the market in the past, and could continue to outperform on a 1-5 year timeline based on analysts’ estimates.

Inside, you’ll get a breakdown of 5 high-quality businesses with:

Strong revenue growth and durable competitive advantages

Attractive valuations based on forward earnings and expected earnings growth

Long-term upside potential backed by analyst forecasts and TIKR’s valuation models

These are the kinds of stocks that can deliver massive long-term returns, especially if you catch them while they’re still trading at a discount.

Whether you’re a long-term investor or just looking for great businesses trading below fair value, this report will help you zero in on high-upside opportunities.

Click here to sign up for TIKR and get our full report on 5 undervalued compounders completely free.

Looking for New Opportunities?

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!"